CANSORTIUM


Associated tags: CSE, OTCQX, Elevate, Drug

Locations: PENSACOLA, TX, JAMAICA, ECUADOR, TOGO, MI, TAMPA, FL, US, FLORIDA, PENNSYLVANIA, MICHIGAN, TEXAS

Cansortium Schedules Fourth Quarter 2023 Conference Call for Monday, April 29 at 4:30 P.M. ET

Retrieved on: 
Thursday, April 25, 2024

The Company will issue a press release with its results prior to the call.

Key Points: 
  • The Company will issue a press release with its results prior to the call.
  • Cansortium management will host the conference call, followed by a question-and-answer period.
  • Interested parties may submit questions to the Company prior to the call by emailing [email protected] .
  • Please call the conference telephone number 5-10 minutes prior to the start time.

Florida's Premier Medical Marijuana Provider FLUENT™ Expands with New Dispensary in Daytona Beach

Retrieved on: 
Friday, April 5, 2024

Patients with a valid medical marijuana card and ID can now explore FLUENT's sought-after selection of premium cannabis products, including flower, concentrates, edibles, tinctures and more.

Key Points: 
  • Patients with a valid medical marijuana card and ID can now explore FLUENT's sought-after selection of premium cannabis products, including flower, concentrates, edibles, tinctures and more.
  • “Our new storefront in the vibrant city of Daytona Beach exemplifies our dedication to creating a seamless and convenient patient experience,” said Robert Beasley, CEO of FLUENT.
  • “Up until now, coastal residents would have to travel up north to Jacksonville or south to Cocoa to reach a FLUENT dispensary.
  • Florida residents interested in obtaining a medical marijuana card can visit GetFLUENT.com/GetYourCard to learn more.

FLUENT Prioritizes Reinvestment into Florida-Based Cultivation Facilities with Multiple Renovations and Expansions

Retrieved on: 
Wednesday, March 13, 2024

“To keep up with today’s vertical medical marijuana market in Florida, it’s imperative for companies to reinvest into their ecosystem when they can to stay in balance,” said Robert Beasley, CEO of FLUENT.

Key Points: 
  • “To keep up with today’s vertical medical marijuana market in Florida, it’s imperative for companies to reinvest into their ecosystem when they can to stay in balance,” said Robert Beasley, CEO of FLUENT.
  • “Our individual store sales continue to increase, and we intend to continue to add additional stores each quarter.
  • With a phased approach that began in February of this year, FLUENT plans to bring 40 new employment opportunities to the Tampa area region once renovations are completed by the end of 2024.
  • Approved for operation in February, the Ruskin facility touts a combination of greenhouse and indoor cannabis cultivation across over 20,000 square feet, bringing 15 new employment opportunities to the community.

FLUENT Opens 34th Medical Cannabis Dispensary in Cocoa, Florida; 37th Nationwide

Retrieved on: 
Monday, January 22, 2024

TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTCQB: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, announced the opening of its 34th medical cannabis dispensary in Florida and 37th retail location nationwide.

Key Points: 
  • TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTCQB: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, announced the opening of its 34th medical cannabis dispensary in Florida and 37th retail location nationwide.
  • FLUENT Cocoa is located at 941 N Cocoa Blvd, Cocoa, FL 32922.
  • The new 2,600 square foot dispensary is the first dispensary in Cocoa with a cannabis drive-thru which will increase accessibility, improve service speed and provide the utmost discretion for patients.
  • “We look forward to servicing the Cocoa community with the first drive-thru cannabis dispensary in the area, offering friendly service and a vast assortment of products,” said FLUENT Director of Marketing David Letro.

Cansortium Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 29, 2023

TAMPA, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the third quarter ended September 30, 2023. Unless otherwise indicated, all financial results are presented in U.S. dollars.

Key Points: 
  • - Q3 Cash from Operations increased 32% to a Record $7.1 Million;
    TAMPA, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTCQB: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the third quarter ended September 30, 2023.
  • Unless otherwise indicated, all financial results are presented in U.S. dollars.
  • Cash flow from operations for the three months ended September 30, 2023 was $7.1 million compared to $5.4 million in the prior year.
  • The Company anticipates opening 1 additional new store in Florida by the end of 2023.

Cansortium Announces Shares for Debt Settlement

Retrieved on: 
Friday, November 10, 2023

The Debt Shares are being issued at a price equal to the closing market price of the common shares of the Company as listed on the Canadian Securities Exchange (“CSE”) on September 30, 2023, being US$0.095, in accordance with the policies of the CSE.

Key Points: 
  • The Debt Shares are being issued at a price equal to the closing market price of the common shares of the Company as listed on the Canadian Securities Exchange (“CSE”) on September 30, 2023, being US$0.095, in accordance with the policies of the CSE.
  • The issuance of the Debt Shares to the directors constitutes a "related party transaction" as this term is defined in Multilateral Instrument 61-101 - Protection of Minority Securityholders in Special Transactions (“MI 61-101”).
  • The directors of the Company, acting in good faith, determined that the fair market value of the Debt Shares being issued pursuant to the shares for debt transaction and the consideration being paid is reasonable.
  • Any Debt Shares issued will be subject to a four (4) month hold period.

Cansortium Reschedules Third Quarter 2023 Conference Call for Wednesday, November 29 at 4:30 P.M. ET

Retrieved on: 
Friday, November 10, 2023

The Company will issue a press release with its results prior to the call.

Key Points: 
  • The Company will issue a press release with its results prior to the call.
  • Cansortium management will host the conference call, followed by a question-and-answer period.
  • Interested parties may submit questions to the Company prior to the call by emailing [email protected] .
  • If you have any difficulty connecting with the conference call, please contact Elevate IR at (720) 330-2829.

Cansortium Schedules Third Quarter 2023 Conference Call for Monday, November 13 at 4:30 P.M. ET

Retrieved on: 
Monday, November 6, 2023

TAMPA, Fla., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTC: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, will hold a conference call to discuss its financial and operating results for the third quarter ended September 30, 2023.

Key Points: 
  • TAMPA, Fla., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTC: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, will hold a conference call to discuss its financial and operating results for the third quarter ended September 30, 2023.
  • The Company will issue a press release with its results prior to the call.
  • Cansortium management will host the conference call, followed by a question-and-answer period.
  • If you have any difficulty connecting with the conference call, please contact Elevate IR at (720) 330-2829.

Cansortium Reports Second Quarter 2023 Results

Retrieved on: 
Monday, August 28, 2023

TAMPA, Fla., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the second quarter ended June 30, 2023. Unless otherwise indicated, all financial results are presented in U.S. dollars.

Key Points: 
  • - Q2 Cash from Operations of $4.8 Million; 7th Consecutive Quarter of Positive Cash Flow -
    TAMPA, Fla., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTCQX: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the second quarter ended June 30, 2023.
  • “We continued to drive revenue growth and cash flow generation during the second quarter through a combination of organic growth as well as new store openings in Florida,” said CEO Robert Beasley.
  • And in Texas, we logged our first B2B sale during the quarter and continue to expect opening our brick-and-mortar delivery center in Houston in the coming months.
  • In Florida, Cansortium currently operates 33 stores and anticipates opening an additional 1-2 new stores by the end of 2023.

Cansortium Announces Results of Annual General and Special Meeting of Shareholders

Retrieved on: 
Wednesday, August 23, 2023

TAMPA, Fla., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTCQX: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, is pleased to announce the voting results from its annual general and special meeting of shareholders (the “Meeting”) held on August 16, 2023.

Key Points: 
  • TAMPA, Fla., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cansortium Inc. ( CSE: TIUM.U ) ( OTCQX: CNTMF ) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, is pleased to announce the voting results from its annual general and special meeting of shareholders (the “Meeting”) held on August 16, 2023.
  • All matters presented to the Meeting were approved by the Company’s shareholders, including:
    the election of five nominees to the board of directors as proposed by the Company in its management information circular, being Robert Beasley, Roger Daher, Mark Eckenrode, William Smith and John Mazarakis;
    the re-appointment of Baker Tilly US, LLP as auditor of the Company;
    the re-approval of the Company’s stock option plan for a further three years, including the approval of all unallocated stock options to purchase common shares of the Company (“Common Shares”), in accordance with the policies of the Canadian Securities Exchange (the “CSE”); and
    the re-approval of the Company's restricted share unit award plan for a further three years, including the approval of all unallocated restricted share units to receive Common Shares, in accordance with the policies of the CSE.